Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning

Prostate cancer is the most common cancer in men in the Western world. One-third of the patients with prostate cancer will develop resistance to hormonal therapy and progress into metastatic castration-resistant prostate cancer (mCRPC). Currently, docetaxel is a preferred treatment for mCRPC. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Kaiwen, Li, Hongyang, Guan, Yuanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976944/
https://www.ncbi.nlm.nih.gov/pubmed/31978751
http://dx.doi.org/10.1016/j.isci.2019.100804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976944/
https://www.ncbi.nlm.nih.gov/pubmed/31978751
http://dx.doi.org/10.1016/j.isci.2019.100804

Ejemplares similares